Stem Cell Infusion: Clinical Trials

35 trials of Stem Cell Infusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 14 terminated, 2 recruiting, 2 withdrawn. 35 Phase 2, 9 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 235Completed 15, Terminated 14, Recruiting 2, Withdrawn 2, Active not recruiting 1, Unknown 1
Phase 19Terminated 5, Completed 3, Withdrawn 1
Phase 32Completed 1, Terminated 1

Follow Stem Cell Infusion: new trials by email Literature Review of Stem Cell Infusion trials Research Report on Stem Cell Infusion

Trials (filtered) newest first · largest first

All 35 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
Treosulfan, Fludarabine, Total Body Irradiation - AML, MDS
Phase 2RecruitingMasonic Cancer Center, University of Minnesota1322026-04-102026-04-16
Siplizumab for Sickle Cell Disease Transplant
Siplizumab, Exchange Transfusion, Total Body Irradiation - Anemia, Sickle Cell
Phase 1 / Phase 2TerminatedColumbia University12023-09-282026-06-10
Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma
Palifermin, Panobinostat, Gemcitabine - Lymphoma
Phase 2WithdrawnM.D. Anderson Cancer Center2017-06-012017-04-21
Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
ATG, fludarabine, cyclophosphamide - Sickle Cell Disease
Phase 2RecruitingUniversity of Illinois at Chicago502017-03-202026-07-08
Autologous Stem Cell Study for Adult TBI (Phase 2b)
Placebo Infusion, Autologous BMMNC Infusion - Brain Injuries, Traumatic, Brain Injuries, Acute
Phase 2UnknownThe University of Texas Health Science Center, Houston372016-11-212024-05-09
Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)
Busulfan, Fludarabine, Clofarabine - Leukemia
Phase 2CompletedM.D. Anderson Cancer Center112015-09-142024-02-22
Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
Fludarabine, Melphalan, Alemtuzumab - Leukemia, Myeloma
Phase 1 / Phase 2TerminatedM.D. Anderson Cancer Center32013-12-272019-07-16
CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma
Cyclophosphamide, Doxorubicin, Vincristine - T-cell Non-Hodgkin Lymphoma
Phase 2TerminatedDana-Farber Cancer Institute52013-07-012023-01-30
Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation
Bortezomib, Carmustine, Etoposide - Multiple Myeloma
Phase 2TerminatedWashington University School of Medicine102012-09-012014-10-15
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
Fludarabine monophosphate, Busulfan, Stem Cell Infusion - Leukemia, Acute Myeloid Leukemia
Phase 2CompletedM.D. Anderson Cancer Center2012012-04-112023-06-29
Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)
Fludarabine, Melphalan, Alemtuzumab - Leukemia, Lymphoma
Phase 2TerminatedM.D. Anderson Cancer Center162012-02-012016-03-17
Clinical Trial I/II Opened, Randomized and Controlled for the Study of the Use of Stem Cells Therapy in Insulinized Diabetic Patients Type 2 With Critical Ischemia in Lower Limbs (CLI): Study of the Needs of Insulin
Stem cell infusion - Critical Limb Ischemia (CLI)
Phase 1 / Phase 2TerminatedAndalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud202011-09-012018-12-19
Lenalidomide and High-Dose Melphalan
Lenalidomide, Melphalan, Stem Cell Infusion - Myeloma, Stem Cell Transplantation
Phase 1 / Phase 2CompletedM.D. Anderson Cancer Center612010-03-012016-06-06
Safety and Effectiveness of Cord Blood Stem Cell Infusion for the Treatment of Cerebral Palsy in Children
Cord Blood Infusion, Intravenous Sham - Cerebral Palsy
Phase 1 / Phase 2WithdrawnAugusta University2010-01-012022-10-07
Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
Stem cell infusion, TLI, Anti-thymocyte globulin - Lymphoma, Non-Hodgkin
Phase 2Active not recruitingWashington University School of Medicine182009-05-052026-02-02
Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis
filgrastim, bortezomib, melphalan - Multiple Myeloma
Phase 2CompletedBoston Medical Center102008-06-012017-02-06
Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden
Melphalan, Stem Cell Infusion, Questionnaires - Multiple Myeloma, Primary Amyloidosis
Phase 2CompletedM.D. Anderson Cancer Center802008-03-012020-01-14
Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation
Clofarabine, Cytarabine, Thymoglobulin - Myelodysplastic Syndromes, Acute Myeloid Leukemia
Phase 2TerminatedWashington University School of Medicine72007-11-012014-09-12
Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma
Carboplatin, Etoposide, Melphalan - Neuroblastoma
Phase 2 / Phase 3TerminatedM.D. Anderson Cancer Center32007-10-012019-07-26
Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency Disorders
Campath -1H, Fludarabine, Anti-CD45 - Severe Combined Immunodeficiency Disease, Severe Primary Immunodeficiency Disorder
Phase 1 / Phase 2TerminatedBaylor College of Medicine32007-10-012013-07-02

Showing 20 of 35. Sign in to see all of them.

Conditions studied

Multiple Myeloma (12)  ·  Myelodysplastic Syndromes (8)  ·  Leukemia, Myeloid, Acute (7)  ·  Hodgkin Disease (6)  ·  Leukemia (6)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (5)  ·  Lymphoma (5)  ·  Lymphoma, Non-Hodgkin (5)  ·  Neoplasms, Plasma Cell (5)  ·  Immunoglobulin Light-chain Amyloidosis (4)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (4)  ·  Anemia, Aplastic (3)  ·  Anemia, Sickle Cell (3)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Lymphoma, Follicular (2)

Sponsors

M.D. Anderson Cancer Center (13)  ·  Baylor College of Medicine (6)  ·  Boston Medical Center (3)  ·  Masonic Cancer Center, University of Minnesota (3)  ·  Washington University School of Medicine (3)  ·  Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud (1)  ·  Augusta University (1)  ·  Columbia University (1)  ·  Dana-Farber Cancer Institute (1)  ·  Northwestern University (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  University of Illinois at Chicago (1)

Countries

United States (33)  ·  Spain (1)

Top investigators

Muzaffar H. Qazilbash, MD (2)  ·  Ravi Vij, M.D. (2)  ·  Richard E. Champlin, MD (2)  ·  Robert Krance, MD (2)  ·  Vaishali Sanchorawala, MD (2)  ·  Angela Smith, MD (1)  ·  Bernat Soria (1)  ·  Charles S Cox, MD (1)  ·  Damiano Rondelli, MD (1)  ·  Daniel J. Weisdorf, MD (1)  ·  Issa F. Khouri, MD,BS (1)  ·  James E Carroll, M.D. (1)  ·  Karen Quillen, MD (1)  ·  Kathryn Leung, MD (1)  ·  Keith Stockerl-Goldstein, MD (1)

Results publications

PMID 20946966, PMID 23721329, PMID 29476021, PMID 30389035, PMID 30644983, PMID 30826465